Literature DB >> 26041895

Biographical Feature: James Jorgensen, Ph.D.

.   

Abstract

Mesh:

Year:  2015        PMID: 26041895      PMCID: PMC4508409          DOI: 10.1128/JCM.01422-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  14 in total

Review 1.  Need for susceptibility testing guidelines for fastidious or less-frequently isolated bacteria.

Authors:  James H Jorgensen
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria.

Authors:  James H Jorgensen; Janet F Hindler
Journal:  Clin Infect Dis       Date:  2006-12-07       Impact factor: 9.079

Review 3.  Antimicrobial susceptibility testing: a review of general principles and contemporary practices.

Authors:  James H Jorgensen; Mary Jane Ferraro
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

4.  Collaborative evaluation of an erythromycin-clindamycin combination well for detection of inducible clindamycin resistance in beta-hemolytic streptococci by use of the CLSI broth microdilution method.

Authors:  James H Jorgensen; M Leticia McElmeel; Letitia C Fulcher; Lesley McGee; Sandra S Richter; K P Heilmann; Mary Jane Ferraro; Jean Spargo; Anita Glennen
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

5.  Development of an antimicrobial susceptibility testing method suitable for performance during space flight.

Authors:  J H Jorgensen; J A Skweres; S K Mishra; M L McElmeel; L A Maher; R Mulder; M V Lancaster; D L Pierson
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

6.  Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.

Authors:  Matthew R Moore; Ruth Link-Gelles; William Schaffner; Ruth Lynfield; Catherine Lexau; Nancy M Bennett; Susan Petit; Shelley M Zansky; Lee H Harrison; Arthur Reingold; Lisa Miller; Karen Scherzinger; Ann Thomas; Monica M Farley; Elizabeth R Zell; Thomas H Taylor; Tracy Pondo; Loren Rodgers; Lesley McGee; Bernard Beall; James H Jorgensen; Cynthia G Whitney
Journal:  Lancet Infect Dis       Date:  2015-02-03       Impact factor: 25.071

7.  Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.

Authors:  Cynthia G Whitney; Tamar Pilishvili; Monica M Farley; William Schaffner; Allen S Craig; Ruth Lynfield; Ann-Christine Nyquist; Kenneth A Gershman; Marietta Vazquez; Nancy M Bennett; Arthur Reingold; Ann Thomas; Mary P Glode; Elizabeth R Zell; James H Jorgensen; Bernard Beall; Anne Schuchat
Journal:  Lancet       Date:  2006-10-28       Impact factor: 79.321

8.  Rapid detection of gram-negative bacteriuria by use of the Limulus endotoxin assay.

Authors:  J H Jorgensen; H F Carvajal; B E Chipps; R F Smith
Journal:  Appl Microbiol       Date:  1973-07

9.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

10.  Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci.

Authors:  J H Jorgensen; L M Weigel; M J Ferraro; J M Swenson; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

View more
  1 in total

1.  Biographical Feature: Thomas F. Smith, Ph.D.

Authors:  Erik Munson
Journal:  J Clin Microbiol       Date:  2016-12-21       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.